KindlyMD (NASDAQ:NAKA) Price Target Lowered to $0.50 at B. Riley Financial

KindlyMD (NASDAQ:NAKA) had its target price reduced by B. Riley Financial from $1.00 to $0.50 in a research report report published on Monday,Benzinga reports. They currently have a buy rating on the stock.

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of KindlyMD in a research note on Monday, December 29th. Two equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, KindlyMD presently has an average rating of “Hold” and a consensus price target of $4.25.

KindlyMD Stock Down 0.3%

Shares of NASDAQ:NAKA opened at $0.24 on Monday. The business has a fifty day simple moving average of $0.37 and a 200-day simple moving average of $1.99. KindlyMD has a 52 week low of $0.23 and a 52 week high of $34.77. The company has a market cap of $106.40 million, a P/E ratio of -0.22 and a beta of 31.48.

Institutional Trading of KindlyMD

Institutional investors have recently added to or reduced their stakes in the business. Sagespring Wealth Partners LLC purchased a new position in KindlyMD in the fourth quarter valued at about $28,000. SG Americas Securities LLC purchased a new stake in shares of KindlyMD in the fourth quarter worth about $61,000. Virtu Financial LLC acquired a new stake in shares of KindlyMD in the fourth quarter valued at about $151,000. Truist Financial Corp acquired a new stake in shares of KindlyMD in the fourth quarter valued at about $176,000. Finally, Waddell & Associates LLC purchased a new stake in shares of KindlyMD during the 4th quarter valued at about $201,000.

About KindlyMD

Kindly MD, Inc (“KindlyMD” or “Kindly”) is a Utah company formed in 2019. KindlyMD is a healthcare data company, focused on holistic pain management and reducing the impact of the opioid epidemic. KindlyMD offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population. Kindly believes these methods will help prevent and reduce addiction and dependency on opiates. Our specialty outpatient clinical services are offered on a fee-for-service basis.